Delivery Order SPE2DB20D1047-SPE2DB25FF26P

Award Date 11/4/24
Potential Completion Date 11/5/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The $1,642.08 firm fixed price delivery order contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,061.56, is a Firm Fixed Price Delivery Order for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of May 2, 2024. This award is associated with AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product "TYPHIM VI 25 MCG/0.5 ML VIAL 10ML". The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order with a Firm Fixed Price of $7,114.87 and a completion date of April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract, valued at $1,993.19, is a Firm Fixed Price Delivery Order with a completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $3,261.66. The contract is a Firm Fixed Price Delivery Order with a period of performance extending to June 27, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $12,224.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA, covers the procurement of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a medical product used for infectious disease prevention. The contract has a period of performance through February 14, 2025 and...
This federal contract award, valued at $5,404.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of June 26, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product, with a ceiling value of $2,069.70. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 4, 2025. The contract is not set aside and was awarded on June 3, 2025. AmerisourceBergen Drug Corp holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products. The firm fixed price delivery order, valued at $49,761.15, has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award and has received numerous prior contracts from DLA Troop Support...
This contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order contract has a ceiling value of $20,371.16 and a completion date of August 28, 2024. Amerisourcebergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide essential medical commodities, including...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF26P
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $22,891.39, is a delivery order contract with a firm fixed price and a completion date of November 5, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract is not designated as a set-aside contract. The DLA is the funding agency for this award, which falls under its high-level programs for providing essential medical commodities to the U.S. military and other federal healthcare beneficiaries.

Generated 2/3/25, 1:32 PM